About Us

CellSight Technologies is a privately held biotechnology company based in San Francisco, California with additional labs in Los Angeles.

CellSight is enabling cell and gene therapies in living subjects through the use of imaging technologies. We offer custom imaging research services as well as prepackaged molecular imaging kits targeted at companies with imaging expertise as well as academic institutions. We have formed partnerships with large pharmaceutical companies to incorporate imaging studies during cell therapy & drug development.

The technology that forms the basis for the company was developed by Dr. Sanjiv Gambhir's group at the Molecular Imaging Program at Stanford and has been demonstrated in pre-clinical and clinical studies.

Advisory Board

Sanjiv Sam Gambhir, MD, PhD - Chairman of Scientific Advisory Board

Sanjiv Sam Gambhir, MD, PhD

Chairman of Scientific Advisory Board
Director, Molecular Imaging Program at Stanford
World renown figure in molecular imaging with 20 years of biomedical imaging experience. Research focuses on methods to image gene expression in living subjects and imaging fundamental cellular events with optical and radiolabeled probes.
Education:
  • MD and PhD, University of California Los Angeles
Michael Clarke, MD - Scientific Advisory Board

Michael Clarke, MD

Scientific Advisory Board
Associate Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine
Dr. Clarke’s research is aimed at the identifications and characterization of cancer stem cells, and factors that control self-renewal in normal stem cells and their malignant counterparts.
Education:
  • BA and MD, Indiana University

Executive Management

Aruna Gambhir - Chief Executive Officer

Aruna Gambhir

Chief Executive Officer
Previously, Executive Director at Siebel Foundation and Marketing Director at Canary Foundation
Prior to that, 20 years experience in Sales, Marketing, Operations and Engineering in startups and multinational companies
Education:
  • BS Biochemistry, University of California Berkeley
  • MS Computer Science, Santa Clara University
  • MBA, University of California Los Angeles
Sam Quezada - Chief Operating Officer

Sam Quezada

Chief Operating Officer
Most recently IP and Corporate Relationsat the Molecular Imaging Program at Stanford
Nearly 30 years experience in Engineering, Marketing and Operations
Education:
  • BSEE and MBA, Stanford University
Shahriar Yaghoubi, PhD - Chief Technology Officer

Shahriar Yaghoubi, PhD

Chief Technology Officer
Managed several industry sponsored pre-clinical imaging projects
Director of Therapeutic Cell Imaging Trials and lead for FDA IND approval for [18F]FHBG
Over twelve years of experience in Molecular Imaging research at Stanford and UCLA
Education:
  • BS Biomedical Engineering, University of Southern California
  • PhD Molecular Medical Pharmacology, University of California Los Angeles
Sunetra Ray, PhD - Research Scientist

Sunetra Ray, PhD

Research Scientist
Broad experience in molecular pharmacology with specific training and expertise in molecular biology and molecular imaging
Past work experience includes conducting preclinical DMPK studies for a CRO
Over seven years of experience in Molecular Imaging research at Stanford and UCLA
Education:
  • B.Pharmacy, Jadavpur University, India
  • MS Pharmacology, University of Toledo, Ohio
  • PhD Molecular Medical Pharmacology, University of California Los Angeles